Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with osteoporosis at highest risk for fracture.

MLA

DeSapri, Kristi Tough, et al. “Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture.” Menopause (New York, N.Y.), Feb. 2025. EBSCOhost, https://doi.org/10.1097/GME.0000000000002516.

APA

DeSapri, K. T., Clarke, B. L., Kostenuik, P., Wang, Y., & Mitlak, B. H. (2025). Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with osteoporosis at highest risk for fracture. Menopause (New York, N.Y.). https://doi.org/10.1097/GME.0000000000002516

Chicago

DeSapri, Kristi Tough, Bart L Clarke, Paul Kostenuik, Yamei Wang, and Bruce H Mitlak. 2025. “Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture.” Menopause (New York, N.Y.), February. doi:10.1097/GME.0000000000002516.